Zai Lab Limited to present at the 36th Annual J.P. Morgan Healthcare Conference

SHANGHAI, China, Jan. 03, 2018 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based innovative biopharmaceutical company, today announced that Chief Executive Officer, Samantha Du, will present at the 36th Annual J.P. Morgan Healthcare Conference. 

Details of the presentation are as follows:

The 36th Annual J.P. Morgan Healthcare Conference
Date: Wednesday, January 10, 2018
Location: San Francisco, CA, USA
Presentation Time: 10:00 AM PT

Individuals may access a live webcast of the conference presentation on the Zai Lab website at under “Events & Presentations” in the “Investors” section.  A replay of the webcast will be available on this site for 90 days following the live event.

About Zai Lab
Zai Lab (NASDAQ:ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company’s experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China’s pharmaceutical market and global unmet medical needs. Zai Lab’s vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partners’ and its own products in order to impact human health worldwide.


Zai Lab
Jonathan Wang
+86 21 6163 2588

The Trout Group
John Graziano
+1 646 378 2942